May 28, 2026
2 min read
Add topic to email alerts
Receive an email when new articles are posted on
Please provide your email address to receive an email when new articles are posted on .
Patients with systemic autoimmune rheumatic disease demonstrate an increased persistence of SARS-CoV-2 antigen positivity up to 6 months after COVID-19 infection, according to data published in Arthritis & Rheumatology.“Longer duration of SARS-CoV-2 antigen persistence in the blood has been associated with various outcomes including higher risk of post-acute sequelae of COVID-19,”
May 28, 2026
2 min read
Add topic to email alerts
Receive an email when new articles are posted on
Please provide your email address to receive an email when new articles are posted on .

CHICAGO — Patients with autoimmune and rheumatic diseases who received antiviral therapy for COVID-19 demonstrated reduced…

Serological profiling detected distinct immune-response changes long before symptoms emerged among patients who developed…

A dual-target CD19/BCMA chimeric antigen receptor T-cell therapy yielded “profound, sustained” remission in 11 patients with…

The emergence of biologic therapies ushered in an era of unprecedented positive outcomes for patients with rheumatic and…

ORLANDO — Following hospitalization for an exacerbation of interstitial lung disease related to systemic autoimmune rheumatic…

Depression and inflammation may be intimately linked through connections between the brain and the immune system, according a…